| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/20/2002 | EP1180110A1 13-methyl-erythromycin derivatives |
| 02/20/2002 | EP1180102A1 Mutual prodrugs of amlodipine and atorvastatin |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020018810 Controlled release oxycodone compositions |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178808A1 Pharmaceutical composition |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335843A Thiourea inhibitors of herpes viruses |
| 02/13/2002 | CN1335839A Bis-sulfonamides |
| 02/13/2002 | CN1335774A Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 02/13/2002 | CN1335766A A process for the preparation of suspensions of drug particles for inhalation delivery |
| 02/13/2002 | CN1079027C Medical composition for treating diabetes |
| 02/07/2002 | WO2002010163A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | US20020016463 Partial fatty acid oxidation inhibitors; protect skeletal muscles against damage resulting from trauma or systemic diseases, treat shock conditions, preserve donor tissue and organs used in transplants |
| 02/07/2002 | CA2417260A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/06/2002 | CN1334816A Triazolo (4,5-D) pyrimidine compounds |
| 02/05/2002 | CA2242373C Teas for the amelioration of the effects of alcoholic drinks and processes for the production thereof |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/31/2002 | US20020013358 Indole derivatives |
| 01/30/2002 | EP1175429A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
| 01/30/2002 | EP1175428A1 3-deoxy-desmycosin derivatives and process for their preparation |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | CN1333698A Combination chemotherapy |
| 01/30/2002 | CN1333682A Storable active substance concentrate with formoterol |
| 01/24/2002 | US20020009509 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 01/23/2002 | EP1173210A1 Contraceptive compositions containing antiprogestinic and progestinic |
| 01/23/2002 | EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 01/23/2002 | EP0941103B1 Pharmaceutical composition for treatment of diabetes |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/22/2002 | US6340695 Rapid onset formulation |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/16/2002 | EP1171142A1 Inflammatory mediation obtained from atractylodes lancea |
| 01/16/2002 | CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331594A Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/09/2002 | CN1330548A Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agents |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/02/2002 | EP1165576A1 Process for preparing amine platinum complexes |
| 01/02/2002 | EP1165553A1 C10 ester substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165552A1 C7 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165550A1 C10 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165528A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165069A1 Antitumour synergistic composition |
| 01/02/2002 | CN1329605A Benzofuran derivatives their preparation and use |
| 01/01/2002 | US6335345 Spiro compounds |
| 12/27/2001 | WO2001034189A3 Vaccines for mycoplasma bovis and methods of use |
| 12/27/2001 | US20010055625 Herbal composition and method of manufacturing such composition for the management of gynecological disorders |
| 12/26/2001 | CN1328554A Eletriptan hydrobromide monohydrate |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 12/20/2001 | WO2000066602A9 3-deoxy-desmycosin derivatives and process for their preparation |
| 12/19/2001 | EP1163000A2 Vaccine against antigens from bacteriae |
| 12/19/2001 | EP1162999A2 Vaccine against Streptococcus pneumoniae |
| 12/19/2001 | EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 12/19/2001 | CN1076356C Protein having TPO activity |
| 12/13/2001 | WO2001094341A1 Quinazoline derivatives for the treatment of tumours |
| 12/13/2001 | US20010051640 C7 carbamoyloxy substituted taxanes |
| 12/06/2001 | WO2001092282A2 Methods and compositions for treating flaviviruses and pestiviruses |
| 12/06/2001 | WO2001092239A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/06/2001 | WO2001092230A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 12/06/2001 | WO2001091756A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
| 12/06/2001 | CA2410618A1 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders |
| 12/06/2001 | CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists |
| 12/05/2001 | EP1159966A2 Composition for the treatment of psoriasis |
| 12/04/2001 | US6326375 Containing an urea group |
| 11/28/2001 | EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 11/28/2001 | EP1156814A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 11/28/2001 | CN1324348A TAN-1057 derivatives |
| 11/22/2001 | WO2001087841A1 Novel polymorph v of torasemide |
| 11/22/2001 | CA2409699A1 Novel polymorph v of torasemide |
| 11/21/2001 | EP1155000A1 2-aminopyridines containing fused ring substituents |
| 11/21/2001 | EP1154987A1 Phenylalaninol derivatives |
| 11/15/2001 | US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production |
| 11/15/2001 | DE10113328A1 New herbal composition for treating gynecological and other related disorders comprises solvent extracted herbal extract and a plant coagulate |
| 11/14/2001 | EP1152755A1 Essential fatty acids in the prevention of cardiovascular events |
| 11/14/2001 | EP1003537B1 Composition comprising propolis and at least an essential oil |
| 11/13/2001 | US6316504 Administering r(+)-n-propargyl-1-aminoindan or its salt for therapy of multiple sclerosis |
| 11/13/2001 | US6315873 Method of forming a fluoride film |
| 11/08/2001 | WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 11/08/2001 | WO2001044242A9 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 11/07/2001 | EP1150991A2 Compositions for treating inflammatory response |
| 11/07/2001 | EP1150679A1 Use of cholesterol-lowering agent |
| 11/07/2001 | EP1150678A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 10/31/2001 | EP1149083A1 Morpholinobenzamide salts |
| 10/31/2001 | EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors |
| 10/25/2001 | WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 10/24/2001 | EP1147114A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 10/24/2001 | EP1146886A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 10/18/2001 | WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 10/17/2001 | EP1144396A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 10/11/2001 | WO2001074820A1 Novel derivatives and analogues of galanthamin |